The Tax Cuts and Jobs Act (TCJA) of 2017 initiated a profound and immediate disruption to the tax treatment of research and experimental (R&E) expenditures, effectively terminating the long-standing option for immediate expensing under Section 174 of the Internal Revenue Code. For tax years beginning after December 31, 2021, the TCJA mandated that all Specified […]